NDC 71288-166
Pemetrexed
Pemetrexed Disodium
Pemetrexed is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Pemetrexed Disodium Hemipentahydrate.
| Product ID | 71288-166_3c71d440-53f5-413b-8718-0d7c4be0dbf5 |
| NDC | 71288-166 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pemetrexed |
| Generic Name | Pemetrexed Disodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-05-25 |
| Marketing Category | ANDA / |
| Application Number | ANDA208696 |
| Labeler Name | Meitheal Pharmaceuticals Inc. |
| Substance Name | PEMETREXED DISODIUM HEMIPENTAHYDRATE |
| Active Ingredient Strength | 100 mg/10mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |